HIGHLIGHTS
- who: Elias A. T. Koch and collaborators from the Department of Dermatology, Universitu00e4tsklinikum Erlangen, Friedrich-Alexander-University , Erlangen, Germany have published the research: Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity, in the Journal: Cancers 2022, 14, 518. of 22/Nov/2021
- what: The authors provide hitherto the first analysis of ICB in UM. The authors investigated the value of ICB re-induction in a large nationwide collective of patients with metastatic UM. This study was approved by the scientific board of the ADOReg registry, the institutional review board of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.